GO
Loading...

Allergan Inc

More

  • NEW YORK/ BOSTON, Aug 20- A few months ago, an innovative partnership between Valeant Pharmaceuticals and billionaire investor William Ackman to buy Botox maker Allergan Inc looked like a blueprint for success.

  • Final Glance: Medical Devices companies Tuesday, 19 Aug 2014 | 6:09 PM ET

    Allergan rose $6.21 or 4.0 percent, to $161.82. Baxter International Inc. fell$. 08 or. 1 percent, to $75.13. Boston Scientific Corp. fell$. 05 or. 4 percent, to $12.59.

  • Midday Glance: Medical Devices companies Tuesday, 19 Aug 2014 | 4:03 PM ET

    Allergan rose $1.15 or. 7 percent, to $156.76. Baxter International Inc. rose$. 01 or percent, to $75.22. Boston Scientific Corp. fell$. 07 or. 6 percent, to $12.57.

  • Aug 19- Botox maker Allergan Inc has approached Salix Pharmaceuticals Ltd and at least one other company about a potential takeover in a bid to avert the $53 billion hostile takeover from Valeant Pharmaceuticals International Inc, the Wall Street Journal said. Allergan and Salix declined to comment on the matter.

  • Final Glance: Medical Devices companies Monday, 18 Aug 2014 | 6:02 PM ET

    Allergan fell $2.65 or 1.7 percent, to $155.61. Baxter International Inc. rose$. 80 or 1.1 percent, to $75.21. Boston Scientific Corp. rose$. 18 or 1.4 percent, to $12.64.

  • Allergan names Hindman chief financial officer Monday, 18 Aug 2014 | 1:12 PM ET

    IRVINE, Calif.— Botox maker Allergan, which is fighting a hostile takeover bid from Valeant Pharmaceuticals, has named longtime executive Jim Hindman its new chief financial officer. Allergan Chairman and CEO David E.I. Pyott said in a statement from the company that Edwards told him back in February that he was thinking about stepping down later in the year.

  • Early Glance: Medical Devices companies Monday, 18 Aug 2014 | 10:29 AM ET

    Allergan fell $1.26 or. 8 percent, to $157.00. Baxter International Inc. rose$. 81 or 1.1 percent, to $75.22. Boston Scientific Corp. rose$. 14 or 1.1 percent, to $12.60.

  • Final Glance: Medical Devices companies Friday, 15 Aug 2014 | 6:16 PM ET

    Allergan rose $2.66 or 1.7 percent, to $158.26. Baxter International Inc. fell$. 34 or. 5 percent, to $74.41. Boston Scientific Corp. fell$. 12 or 1.0 percent, to $12.46.

  • Midday Glance: Medical Devices companies Friday, 15 Aug 2014 | 1:15 PM ET

    Allergan rose $2.17 or 1.4 percent, to $157.77. Baxter International Inc. fell$. 54 or. 7 percent, to $74.21. Boston Scientific Corp. fell$. 15 or 1.2 percent, to $12.43.

  • Early Glance: Medical Devices companies Friday, 15 Aug 2014 | 11:21 AM ET

    Allergan rose $3.59 or 2.3 percent, to $159.19. Baxter International Inc. rose$. 38 or. 5 percent, to $75.13. Johnson& Johnson rose$. 07 or. 1 percent, to $102.09.

  • BOSTON, Aug 14- Billionaire investor William Ackman, who often says he is flattered when others follow him into a stock he likes, was joined by several prominent hedge funds that made new bets on takeover target Allergan Inc during the second quarter.

  • Aug 14- Pershing Square Capital Management LP, the hedge fund firm run by William Ackman, has sued the U.S. government, claiming that its stripping of Fannie Mae's and Freddie Mac's profit illegally short changes investors in the mortgage companies' common stock.

  • Aug 14- U.S. securities regulators are looking at the hostile takeover bid made by billionaire investor William Ackman and Valeant Pharmaceuticals for Botox maker Allergan Inc, a person familiar with the matter said on Thursday.

  • Aug 14- A hostile takeover bid by billionaire investor William Ackman and Valeant Pharmaceuticals International Inc to acquire Allergan Inc is being investigated by federal regulators for possible violations of securities laws, the Wall Street Journal reported, citing people familiar with the matter.

  • Daniel Loeb's Third Point added 1 million shares of Dollar General, raising his stake by 33 percent, while Blue Ridge Capital, founded by Tiger Cub John Griffin, nearly doubled its stake in Walgreen when it bought 2.8 million shares.

  • Bill Ackman plans to raise $4B through listed fund Thursday, 14 Aug 2014 | 2:19 AM ET
    Bill Ackman

    Bill Ackman is planning to raise around $4 billion by listing a new investment vehicle in London, the FT reports.

  • Final Glance: Medical Devices companies Wednesday, 13 Aug 2014 | 6:14 PM ET

    Allergan rose $1.86 or 1.2 percent, to $154.90. Baxter International Inc. rose$. 69 or. 9 percent, to $74.96. Boston Scientific Corp. rose$. 11 or. 9 percent, to $12.48.

  • Midday Glance: Medical Devices companies Wednesday, 13 Aug 2014 | 1:50 PM ET

    Allergan rose $2.11 or 1.4 percent, to $155.15. Baxter International Inc. rose$. 61 or. 8 percent, to $74.88. Boston Scientific Corp. rose$. 11 or. 9 percent, to $12.48.

  • Early Glance: Medical Devices companies Wednesday, 13 Aug 2014 | 10:32 AM ET

    Allergan rose $1.27 or. 8 percent, to $154.31. Baxter International Inc. rose$. 49 or. 7 percent, to $74.76. Boston Scientific Corp. rose$. 01 or. 1 percent, to $12.39.

  • Faber Report: Hostile bids hard to do     Tuesday, 12 Aug 2014 | 9:39 AM ET

    CNBC's David Faber discusses just how hard hostiles are for companies to execute, after the canceled unsolicited bid between Time Warner and 21st Century Fox, and other companies recently. Faber provides an update on Valeant's battle for Allergan.